Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study

BACKGROUND: Primaquine is the only licensed drug for eradicating Plasmodium vivax hypnozoites and, therefore, preventing relapses of vivax malaria. It is a vital component of global malaria elimination efforts. Primaquine is efficacious when supervised in clinical trials, but its effectiveness in re...

Descripción completa

Detalles Bibliográficos
Autores principales: Douglas, Nicholas M., Poespoprodjo, Jeanne Rini, Patriani, Dewi, Malloy, Michael J., Kenangalem, Enny, Sugiarto, Paulus, Simpson, Julie A., Soenarto, Yati, Anstey, Nicholas M., Price, Ric N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574534/
https://www.ncbi.nlm.nih.gov/pubmed/28850568
http://dx.doi.org/10.1371/journal.pmed.1002379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574534/
https://www.ncbi.nlm.nih.gov/pubmed/28850568
http://dx.doi.org/10.1371/journal.pmed.1002379

Ejemplares similares